Top Partnering Opportunities in CV/Metabolics: A Shifting Marketplace
Executive Summary
Higher barriers to entry have made deals in the cardiovascular and metabolics spaces increasingly difficult, but novel therapeutic approaches coupled with unmet metabolic need – especially in type 2 diabetes – are keeping both of these fields top of mind.